epilepsie Epilepsy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Diagnosed with epilepsy - Using anti-epileptic drugs - Age at least 18 years - Living at home (Netherlands) - Able and willing to use a smartphone in the program. - Able to provide informed consent
Exclusion criteria
Exclusion criteria: - Insufficient mental ability to understand, learn from and profit from the self-management intervention on the basis of clinical judgement of the treating neurologist. - Insufficient command of the Dutch language based on clinical judgement. - Inability to function in a group because of mood or behavioural problems as assessed by the neurologist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome for the (cost) effectiveness study is self-efficacy measured with Epilepsy Self-Efficacy Scale (ESES); | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes for the (cost)-effectiveness study are adherence measured by Monitor Adherence Response Scale (MARS) and Medication Event Monitoring System (MEMS), general self-efficacy measured by Generalized Self-efficacy Scale (GSES) and generic quality of life as measured with the EuroQol-5D and the AQOL-8D. Other outcome measures are side effects, depression/mood, quality of life, coping skills, societal costs, seizure frequency. | — |
Countries
Netherlands